⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 13, 2024Immunology

Human CD4⁺iNKT cell adoptive immunotherapy induces anti‐tumour responses against CD1d‐negative EBV‐driven B lymphoma

Dana C. Baiu Akshat Sharma Jennifer L. Schehr Jayati Basu Kelsey A. Smith Makoto Ohashi Eric Johannsen Shannon C. Kenney Jenny E. Gumperz

View Full Paper

Ask AI

Bookmark

Share

Abstract

Invariant natural killer T (iNKT) cells are a conserved population of innate T lymphocytes that are uniquely suitable as off-the-shelf cellular immunotherapies due to their lack of alloreactivity. Two major subpopulations of human iNKT cells have been delineated, a CD4

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Baiu et al. (2024) studied this question.

synapsesocial.com/papers/68e6a4ffb6db6435876286cd https://doi.org/10.1111/imm.13799

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1<i>Bona fide</i>cytotoxic iNKT cells with superior antitumour responses identified in mice and humans2024
2invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies2024 · 7 citations
3Abstract B052: Exploring human iNKT cell functionality to enhance adoptive cell therapy against non-small cell lung cancerOriginal Research · 2026
4Generation of iNKT cells with hematopoiesis-promoting properties from human iPSCs2025
5Invariant Natural Killer T Cells in Cancer Immunotherapy: Lipid-Based Modulation, Nanotechnology, and Translational AdvancesOriginal Research · 2026 · 2 citations